MK-3207

· Merck Sharp & Dohme LLC

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MK-3207, covering 2010-11-22 to 2010-11-22. Get the full timeline:

Most recent: Clinical Trial Update: MK3207 for Treatment of Acute Migraines (3207-005) [Phase 2]